Oral 13 cis retinoic acid
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Kafrelsheikh University
Overview
Oral 13 cis retinoic acid is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Oral 13 cis retinoic acid clinical trials
Explore related
Medical disclaimer. This page summarizes research about Oral 13 cis retinoic acid for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.